May 2006
Volume 47, Issue 13
ARVO Annual Meeting Abstract  |   May 2006
Autologous Plasmin Assisted Vitrectomy for Stage 5 Retinopathy of Prematurity
Author Affiliations & Notes
  • Y. Tsukahara
    kobe University, Kobe, Japan
  • S. Honda
    kobe University, Kobe, Japan
  • H. Imai
    kobe University, Kobe, Japan
  • N. Kondo
    kobe University, Kobe, Japan
  • S. Fujii
    Ophthalmology, Hyogo Prefectural Awaji Hospital, Sumoto, Japan
  • N. Yokoyama
    kobe University, Kobe, Japan
  • A. Hirata
    Hayashi Eye Hospital, Fukuoka, Japan
  • H. Tanihara
    Ophthalmology, Kumamoto University, Kumamoto, Japan
  • A. Negi
    kobe University, Kobe, Japan
  • Footnotes
    Commercial Relationships  Y. Tsukahara, None; S. Honda, None; H. Imai, None; N. Kondo, None; S. Fujii, None; N. Yokoyama, None; A. Hirata, None; H. Tanihara, None; A. Negi, None.
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science May 2006, Vol.47, 5313. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Y. Tsukahara, S. Honda, H. Imai, N. Kondo, S. Fujii, N. Yokoyama, A. Hirata, H. Tanihara, A. Negi; Autologous Plasmin Assisted Vitrectomy for Stage 5 Retinopathy of Prematurity . Invest. Ophthalmol. Vis. Sci. 2006;47(13):5313.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: : To study the efficacy and safety of autologous plasmin assisted vitrectomy for stage5 retinopathy of prematurity(ROP) .

Methods: : Consecutive six eyes of four children were treated. Their gestational age was 24 to 26 weeks (mean: 25.0) and birth weight was 652 to 811 grams (mean:701.3). Age at the operation was 5 to 8 months (mean:6.3) after birth. After institutional review board approval, informed consent was obtained from parents of each patient. Autologous plasmin was prepared from patient’s plasma by affinity chromatography. Surgery was performed using limbal approach 23G three–port system. Additional two ports at the limbus was made for easier dissection of peripheral membrane in two cases. After lensectomy, appropriate dissection and removal of proliferative membrane, 0.03 to 0.22 IU of autologous plasmin in 0.1 to 0.15ml solution was administrated into the vitreous cavity. After 20 to 30 minute incubation, residual proliferative membrane was removed. Plasmin was administrated repeatedly in four cases.

Results: : Proliferative membrane was removed without making iatrogenic retinal break and reattachment of posterior pole retina was achieved in all eyes at their last follow–up (4 to 8 months, mean 6.3). Slight fibrin reaction was observed in all eyes postoperatively, which disappeared in several days. No other complication was observed.

Conclusions: : This study suggests the benefit of autologous plasmin during vitrectomy for stage5 ROP.

Keywords: retinopathy of prematurity • vitreoretinal surgery • enzymes/enzyme inhibitors 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.